Literature DB >> 6183317

Urinary-tract infection and bacteraemia in hospitalized medical patients--a European multicentre prevalence survey on nosocomial infection.

O B Jepsen, S O Larsen, J Dankert, F Daschner, P Grönroos, P D Meers, B Nyström, M Rotter, J Sander.   

Abstract

A co-ordinated survey of 3899 medical patients in 169 wards, performed simultaneously in eight countries, showed a point-prevalence of urinary-tract infection (UTI) and bacteraemia of 12.6 and 1.6 per cent, respectively. One-half of the infections were acquired after the patients' admission. The bacteriological patterns of hospital- vs community-acquired infections were different, but showed no unexpected features. Antibiotic treatment was recorded in 22.3 per cent of the patients in this study, urinary-tract disinfectants, sulphonamides or penicillins being used in 95 per cent of those treated for UTI. The overall prevalence of urinary-tract drainage was 11.0 per cent with no significant difference between the two sexes. At ward level the rate of catheterized patients varied from below 5 per cent to more than 25 per cent, indicating--besides variations in the ward populations--differences in policies. The association between nosocomial UTI and the presence of an indwelling catheter and/or female sex was confirmed, while high age appeared to be a secondary risk factor among catheterized patients. The prevalence of nosocomial bacteraemia in patients with UTI was five times higher than in those without urinary-tract involvement, and a significant part of the nosocomial cases of both UTI and bacteraemia was clearly device-related. Guidelines for the use of indwelling catheters should be restrictive and provide for prompt removal. When introduced and followed they will effectively reduce nosocomial UTI and bacteraemia.

Entities:  

Mesh:

Year:  1982        PMID: 6183317     DOI: 10.1016/0195-6701(82)90043-3

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients.

Authors:  A Gündoğdu; Y B Long; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-24       Impact factor: 3.267

2.  Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals.

Authors:  D P Kofteridis; J A Papadakis; D Bouros; P Nikolaides; G Kioumis; S Levidiotou; E Maltezos; S Kastanakis; S Kartali; A Gikas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

3.  Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infection.

Authors:  Hiroyuki Kitano; Norifumi Shigemoto; Yumiko Koba; Toshinori Hara; Kashiyama Seiya; Keitaro Omori; Katsumi Shigemura; Jun Teishima; Masato Fujisawa; Akio Matsubara; Hiroki Ohge
Journal:  World J Urol       Date:  2020-05-03       Impact factor: 4.226

4.  Escherichia coli K1 in urinary tract infections.

Authors:  J Reina; F Salva; J Gil; P Alomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

5.  Primary Staphylococcus aureus urinary tract infection: the role of undetected hematogenous seeding of the urinary tract.

Authors:  I G Baraboutis; E P Tsagalou; J L Lepinski; I Papakonstantinou; V Papastamopoulos; A T Skoutelis; S Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-30       Impact factor: 3.267

6.  The effect of repeated instillations of antiseptics on catheter-associated urinary tract infections: a study in a physical model of the catheterized bladder.

Authors:  J B King; D J Stickler
Journal:  Urol Res       Date:  1992

7.  High proportion of healthcare-associated urinary tract infection in the absence of prior exposure to urinary catheter: a cross-sectional study.

Authors:  Ilker Uçkay; Hugo Sax; Angèle Gayet-Ageron; Christian Ruef; Kathrin Mühlemann; Nicolas Troillet; Christiane Petignat; Enos Bernasconi; Carlo Balmelli; Andreas Widmer; Karim Boubaker; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2013-02-07       Impact factor: 4.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.